Billionaires: 10 Intriguing New Facts About Who’s Getting Rich Now

Billionaires: 10 Intriguing New Facts About Who’s Getting Rich Now

Bank clerk counts Chinese yuan banknotes at a branch of Industrial and Commercial Bank of China in Huaibei
© Stringer China / Reuters
By Ciro Scotti

A new Chinese billionaire was created almost every week in the first quarter of 2015, according to a just-released report by UBS and PwC.

"Asia's billionaires make up 36 percent of self-made billionaire wealth, overtaking Europe for the first time and second only to the U.S.," said Antoinette Hoon, private banking advisory services partner for PwC in Hong Kong. “Looking forward, we expect the region to be the center of new billionaire wealth creation.”

Related: 6 Traits of an Emerging Millionaire: Are You One?

The report, which looked at data for 1,300 billionaires over 19 years, found – unsurprisingly -- that entrepreneurship is a powerful force for wealth creation. “Billionaires: Master architects of great wealth and lasting legacies" also noted that many billionaires are embracing philanthropy to build a legacy.

Here are 10 other findings of the report:

  • 917 self-made billionaires generated more than $3.6 trillion of global wealth between 1995 and 2014.
  • Of them, 23 percent launched their first business before age 30; 68 percent before turning 40.
  •  The second-highest number of self-made American billionaires (27.3 percent) in the last two decades came out of the tech sector.
  • Finance produced 30 percent of U.S. billionaires, but they aren’t as rich as their counterparts in tech; their average net worth is $4.5 billion, compared with $7.8 billion for tech moneybags.
  • In Europe and Asia, self-made billionaires mostly made their money in the consumer industry. Their wealth averages $5.7 billion. Tech entrepreneurs in Europe and Asia were the second-richest group with an average worth of $3.8 billion.
  • More than two-thirds of global billionaires are over 60 years old and have more than one child.
  • The average age of Asia billionaires is 57, 10 years younger than in the U.S. and Europe.
  • About one fourth of Asian billionaires had impoverished childhoods, compared with 8 percent in the U.S. and 6 percent in Europe.
  • 60 percent of self-made billionaires in the U.S. and Europe retain their businesses, 30 percent dispose of part of their business via an IPO or trade sale, with 10 percent selling outright.
  • In Europe and Asia, billionaires are most likely to create a business dynasty, with 57 percent of European and 56 percent of Asian billionaire families, respectively, taking over the family business when the founder retires. In the U.S., just 36 percent of businesses remain family-run once the founder retires.

 

Tax Refunds Rebound

Flickr / Chris Potter
By The Fiscal Times Staff

Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years. 

Number of the Day: $22 Trillion

iStockphoto/The Fiscal Times
By The Fiscal Times Staff

The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.

Chart of the Week: The Soaring Cost of Insulin

Client Sanon has her finger pricked for a blood sugar test in the Family Van in Boston
REUTERS/Brian Snyder
By The Fiscal Times Staff

The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494. 

Chart of the Day: Shutdown Hits Like a Hurricane

An aerial view shows a neighborhood that was flooded after Hurricane Matthew in Lumberton, North Carolina
© CHRIS KEANE / Reuters
By Michael Rainey

The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said. 

Chart of the Week: Lowering Medicare Drug Prices

A growing number of patients are being denied access to newer oral chemotherapy drugs for cancer pills with annual price tags of more than $75,000.
iStockphoto
By Michael Rainey

The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.

In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.